Table 3.
Age-related prevalence of the MetS in subjects with different gender
|
Male |
Female |
|||||||
|---|---|---|---|---|---|---|---|---|
| NGT | IFG/IGT | T2D | P value for trends | NGT | IFG/IGT | T2D | P value for trends | |
| N |
1559 |
1172 |
3376 |
|
782 |
296 |
2072 |
|
| <30 |
18.1%(15/83) |
35.7%(5/14) |
63.9%(115/180)***# |
P<0.001 |
3.3%(3/91)## |
30.0%(3/10)* |
54.9%(39/71)*** |
P < 0.001 |
| %95CI |
(9.6–26.5) |
(7.0–64.4) |
(56.8–71.0) |
(−0.4–7.0) |
(−4.6–64.6) |
(43.1-66.8) |
||
| OR |
Ref |
2.519(0.738–8.591) |
8.021(4.244–15.157) |
Ref |
12.571(2.129–74.233) |
35.750(10.324-123.791) |
||
| 30-39 |
20.0%(42/210) |
73.3%(63/86)*** |
75.1%(410/546)*** |
P<0.001 |
3.8%(4/106)&&& |
34.8%(8/23)***&& |
61.2%(137/224)&&& |
P < 0.001 |
| %95CI |
(14.6–25.5) |
(63.7–82.8) |
(71.5–78.7) |
(0.09–7.5) |
(13.7–55.8) |
(54.7-67.6) |
||
| OR |
Ref |
10.957(6.103–19.669) |
12.059(8.166–17.807) |
Ref |
13.600(3.644–50.754) |
40.155(14.271-112.986) |
||
| 40-49 |
26.1%(130/499) |
69.1%(237/343)*** |
74.2%(783/1055)*** |
P<0.001 |
15.7%(69/441)&&& |
52.0%(93/179)***&&& |
67.8%(328/484)***###& |
P < 0.001 |
| %95CI |
(22.2–29.9) |
(64.2–74.1) |
(71.6–76.9) |
(12.2–19.1) |
(44.6–59.4) |
(63.6-72.0) |
||
| OR |
Ref |
6.346(4.683–8.601) |
8.171(6.409–10.417) |
Ref |
5.830(3.948–8.610) |
11.336(8.232-15.609) |
||
| 50-59 |
28.0%(210/750) |
64.2%(457/712)*** |
74.1%(754/1018)***### |
P<0.001 |
19.7%(28/142)& |
55.0%(44/80)*** |
79.9%(563/705)***###&& |
P < 0.001 |
| %95CI |
(24.8–31.2) |
(60.7–67.8) |
(71.4–76.8) |
|
(13.1-26.3) |
(43.9-66.1) |
(76.9-82.8) |
|
| OR |
Ref |
4.608(3.694-5.749) |
7.344(5.940-9.081) |
Ref |
4.976(2.720-9.104) |
16.142(10.267-25.380) |
||
| ≥60 |
41.2% (7/17) |
41.2%(7/17) |
73.0%(421/577)**## |
P<0.001 | 50.0%(1/2) |
75.0%(3/4) |
84.4%(496/588)&&& |
P = 0.364 |
| %95CI |
(15.1–67.3) |
(15.1–67.3) |
(69.3–76.6) |
(−5.9–6.9) |
(−4.6–154.6) |
(81.4-87.3) |
||
| OR | Ref | 1.000(0.255-3.919) | 3.855(1.442-10.305) | Ref | 3.000(0.084-107.447) | 5.391(0.334-86.965) | ||
Compared with NGT *P<0.05, **P<0.01, ***P<0.001; Compared with IFG/IGT #P<0.05, ##P<0.01, ###P<0.001; Compared with male group &P<0.05, &&P<0.01, &&&P<0.001.